PMED — Peptonic Medical AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK23.04m
- SEK22.65m
- SEK26.89m
Annual cashflow statement for Peptonic Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | — | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -31.3 | -73.7 | -36.9 | -42.6 | -60 |
| Non-Cash Items | 3.29 | 26.8 | 4.65 | 7.05 | 1.9 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -17.8 | 6.51 | -8.01 | 1.73 | 21.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -45.9 | -40.3 | -40.2 | -33.8 | -36.4 |
| Capital Expenditures | -2.82 | -4.28 | -0.987 | -1.93 | -1.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 12.9 | 0.476 | 0 | -17.1 | -5.99 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 10.1 | -3.8 | -0.987 | -19.1 | -7.19 |
| Financing Cash Flow Items | -1.29 | -0.015 | -3.44 | -13.7 | -9.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 39.1 | 15 | 34.6 | 64.4 | 31.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.33 | -29.2 | -6.59 | 11.6 | -11.4 |